Neutralizing antibody titer against: b |
|||||||
|
DENV1 |
DENV2 |
|
DENV4 |
|||
5.0 x 107 |
1:160 |
1:320 |
1:160 |
1:160 |
|||
5.0 x 106 |
1:160 |
1:160 |
1:80 |
1:80 |
|||
5.0 x 105 |
1:80 |
1:80 |
1:80 |
1:20 |
|||
PBS |
1:40 |
1:20 |
1:40 |
1:20 |
|||
aGroups of six 4-week-old male ddY mice were preimmunized with the indicated doses of DENV2 antigen or inoculated with PBS as a control bFour weeks after the preimmunization, mice were vaccinated with 40 µg of the dengue tetravalent DNA vaccine (10 µg for each type) twice, with a 3-week interval. Two weeks after the second dose of the DNA vaccine, mice were bled and pooled sera were examined for neutralizing antibodies |
|||||||
Table 1: Neutralizing antibody titers in dengue tetravalent DNA vaccine-vaccinated mice with or without preimmunization with DENV2.
|